CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs If there was a silver lining in the Covid-19 pandemic, it was the response of the biopharmaceutical industry in generating multiple new vaccines with unprecedented speed – vaccines that promise to bring a sense of normalcy to the world.